Novel Challenges and Advances in Pediatric Hematology and Hematologic Malignancies
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 87
Special Issue Editor
Interests: leukemia; lymphoma; neuroblastoma; hepatoblastoma; nephroblastoma; pediatric hematology; immunotherapyerapy
Special Issue Information
Dear Colleagues,
Recent advancements have significantly improved diagnostics and therapies in pediatric hematology and hematologic malignancies. Immunotherapies, hematopoietic stem cell transplantation in nonmalignant and malignant hematological disorders, the introduction of long half-life coagulation products for patients with hemophilia, and many others have significantly changed the picture of pediatric hematology. However, there is a continuous need for further development in many fields of patient care to improve the prognosis and quality of life for children with hematologic disorders and malignancies.
The Special Issue aims to highlight the latest advances in the clinical, genetic, and therapeutic aspects of children with hematologic disorders or malignancies to provide better information to further improve diagnosis and treatment.
We cordially welcome original research and review submissions covering, but not limited to, the following topics:
- Advances in the diagnosis and therapies of red blood disorders;
- Modern therapies in hemophilia;
- New insights into the diagnosis, prognosis, and therapies of children with thrombocytopenia;
- Recent advances in therapeutic approaches to lymphoid and myeloid neoplasms, including immunotherapies;
- Advances in supportive care measure developments for hematologic patients.
Dr. Katarzyna Pawińska-Wa̧sikowska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric hematology
- hematology malignancies
- therapies
- diagnosis
- immunotherapies
- supportive care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
